PRMT1 and chronic myelogenous leukemia, BCR-ABL1 positive: To investigate whether PRMT1 maintains the self‐renewal of LSCs, we sorted GFP+c‐Kit+ cells from the primary WT or Prmt1 KO CML mice and performed in vitro CFC/replating assay or in vivo disease reconstitution assay (Figure 2M).